Defense Medical Strategies facilitates globally relevant tactical medical research 


DMS has been on the cutting edge of Traumatic Brain Injury research since 2002; assisting the DOD with innovation of computer-based neurocognitive assessment in garrison and on the battlefield. DMS developed a deployable tablet-based system enabling SOF healthcare providers to compare battlefield post-injury assessments with individual baseline data. DMS-formed partnerships demonstrated to the world that mild traumatic brain injury (mTBI) could in-fact be seen on standard Magnetic Resonance Imaging (MRI).

Accurate and immediate detection of mTBI is crucial for making decisions regarding treatment , return to duty (RTD) decisions, and long-term prognosis of the service member (SM). OLAFXIS has established an effective and objective measure of mTBI based on the combination of olfactory (smell) stimulation and electrophysiological activity, using inexpensive, rapidly-assessed, non-invasive electroencephalography (EEG) recordings. Defense Medical Strategies is assisting every step of the way. 

Continuous Precision Medicine has developed an evidence based approach to right-sizing analgesic prescriptions; treating pain while reducing cost, eliminating excess, and optimizing prescribing habits. Defense Medical Strategies is supporting their efforts within the DOD and the healthcare community.


Providing the world of trauma management with a solution for low-volume resuscitation. Perfusion Medical’s polymer of Polyethylene Glycol (PEG-20k) is a promising adjunct for resuscitation of hypovolemic patients. Defense Medical Strategies is right beside them assisting with the FDA approval process.

Caring for those that support our war fighters; EliteCare of Fayetteville provides healthcare screening for the Department of Defense contractors that support the deployed men and women of our armed forces. Defense Medical Strategies provides resources to help make it all possible.

Screen Shot 2019-09-12 at 4.18.48 PM.png

The Fort Bragg Research Institute (FBRI) originated from the requirement to link the vast infrastructure of science and technology regionally available to Womack Army Medical Center (WAMC) with the growing needs of operational readiness for Fort Bragg, NC. Areas of research interest include: biomarker discovery for mild traumatic brain injury, machine learning, real-time genetic sequencing to diagnose infectious agents, non-invasive neurosensory technology to automate combat casualty care records, and miniaturized bio-warfare detection.


The All Secure Foundation assists Special Operations active duty and combat veterans, and their families, in recovery of Post-Traumatic Stress through education, awareness, resources for healing, workshop retreats, and PTS resiliency training. Defense Medical Strategies supports their cause and their operations.

Ligandal - using AI and supercomputing to develop next generation medicine, bringing you nearly a decade of experience in developing peptide-based technologies for gene therapy, gene editing, regenerative medicine, immunotherapy, and advanced antidote-vaccine technologies. Defense Medical Strategies supports their efforts to ensure visibility and traction within the DOD.